Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina
Condition: Yellow Fever Intervention: Biological: Serological study after yellow fever vaccination Sponsors: Ministry of Public Health, Argentina; Centers for Disease Control and Prevention; Pan American Health Organization Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials